Consensus forecasts from equity research analysts tracking electroCore, Inc. (NASDAQ: ECOR) feature an average 12-month price target hovering around $18.00, representing substantial upside from its current trading levels. Projections are anchored by expanding commercial adoption of its non-invasive vagus nerve stimulation devices and narrowing operational net losses.